Trexquant Investment’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.88M Buy
+107,699
New +$7.4M 0.05% 532
2025
Q2
Sell
-8,556
Closed -$425K 1709
2025
Q1
$425K Sell
8,556
-4,318
-34% -$240K ﹤0.01% 1322
2024
Q4
$816K Sell
12,874
-3,201
-20% -$185K 0.01% 1157
2024
Q3
$790K Sell
16,075
-2,526
-14% -$119K 0.01% 1125
2024
Q2
$838K Buy
+18,601
New +$632K 0.01% 1064
2023
Q4
Sell
-12,534
Closed -$589K 1600
2023
Q3
$589K Buy
+12,534
New +$627K 0.01% 953

Other funds holding IRON

Trexquant Investment's IRON Position: Q2 2026 in Review

Trexquant Investment opened a new position in Disc Medicine (IRON) in Q2 2026: 107,699 shares worth $7.88M. The stake represents 0.05% of the portfolio and ranks #532 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in IRON as recently as Q1 2025.

Trexquant Investment first reported a position in IRON in Q3 2023 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Trexquant Investment held 107,699 shares of Disc Medicine worth $7.88M as of Q2 2026.
  • Disc Medicine was a new Trexquant Investment position in Q2 2026.
  • Disc Medicine made up 0.05% of Trexquant Investment's portfolio in Q2 2026, its #532 holding.
  • Trexquant Investment first reported a position in Disc Medicine in Q3 2023 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.